NCT00271674

Brief Summary

The purpose of the study is to compare patient satisfaction, clinical efficacy and adverse effects of Q-switched YAG laser versus punch biopsies for the treatment of tattoo dots that are applied as skin markers in relation to X-ray treatment of malignant disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jan 2006

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

January 3, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 4, 2006

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
Last Updated

June 3, 2008

Status Verified

June 1, 2008

First QC Date

January 3, 2006

Last Update Submit

June 2, 2008

Conditions

Tattoo Skin Markers

Interventions

Q-switched YAG laserDEVICE

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older,
  • Skin types I-IV,
  • No previous laser treatment for the condition.

You may not qualify if:

  • Younger than 18 years,
  • Skin types V-VI,
  • Pregnant or lactating women,
  • Previous laser treatment for the condition,
  • Recent exposure to sun or sun-beds,
  • Treatment with oral retinoids within 3 months,
  • Tendency to produce hypertrophic scars or keloids,
  • Immunosuppressive treatment or disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bispebjerg Hospital

Copenhagen, Copenhagen NV, 2400, Denmark

Location

Study Officials

  • Merete Haedersdal, MD, PhD, DrMedSci.

    Bispebjerg Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 3, 2006

First Posted

January 4, 2006

Study Start

January 1, 2006

Study Completion

December 1, 2007

Last Updated

June 3, 2008

Record last verified: 2008-06

Locations

DK(1)